Olsalazine (Standard)


CAS No. : 15722-48-2

15722-48-2
Price and Availability of CAS No. : 15722-48-2
Size Price Stock
100 mg Get quote
250 mg Get quote
500 mg Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-B0174AR
M.Wt: 302.24
Formula: C14H10N2O6
Purity: >98 %
Solubility:
Introduction of 15722-48-2 :

Olsalazine (Standard) is an orally active prodrug of 5-ASA (HY-15027). Olsalazine (Standard) can inhibit cells proliferation and induce apoptosis. Olsalazine (Standard) can reduce DAI and MPO activity and inhibit inflammatory cytokines levels. Olsalazine (Standard) can be used for the researches of cancer, inflammation and metabolic disease, such as colorectal cancer, inflammatory bowel disease (IBD) and hyperuricemic[1][2][3][4]. IC50 & Target:IC50: 0.39 mM (LTB4)[1] In Vitro:Olsalazine (Standard) (0-30 μM, 48 h) reduces cell viability in canine lymphoid tumor cell[4].
Olsalazine (Standard) (0.19-1.64 μM, 24 h) induces apoptosis in canine lymphoid tumor cell[4].
Olsalazine (Standard) (0.03 μM, 48 h) increases 5-mC levels of genomic DNA in canine lymphoid tumor cell lines[4].
In Vivo:Olsalazine (Standard) (25 mg/kg, i.g., daily for 3 weeks) inhibits tumor growth in colorectal cancer rats models[1].
Olsalazine (Standard) (50 mg/kg, p.o., daily for 11 days) ameliorates colitis companied with Cannabidiol in dextran sulphate sodium (DSS)-induced acute and chronic colitis mice models[2].
Olsalazine (Standard) (Sodium) (5-20 mg/kg) decreases the levels of serum urate in hyperuricemic rats[3].

Your information is safe with us.